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Abstract
 
Protein kinase C (PKC)
 
  
 
is an established component of the immunological synapse and has
been implicated in the control of AP-1 and NF-
 
 
 
B. To study the physiological function of
PKC
 
 
 
, we used gene targeting to generate a PKC
 
  
 
null allele in mice. Consistently, interleukin
2 production and T cell proliferative responses were strongly reduced in PKC
 
 
 
-deficient T
cells. Surprisingly, however, we demonstrate that after CD3/CD28 engagement, deficiency of
PKC
 
  
 
primarily abrogates NFAT transactivation. In contrast, NF-
 
 
 
B activation was only par-
tially reduced. This NFAT transactivation defect appears to be secondary to reduced inositol
1,4,5-trisphosphate generation and intracellular Ca
 
2
 
  
 
mobilization. Our finding suggests that
PKC
 
  
 
plays a critical and nonredundant role in T cell receptor–induced NFAT activation.
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Introduction
 
The protein kinase C (PKC)
 
* 
 
is not a single entity but con-
 
stitutes, at the gene level, nine different isotypes: PKC
 
 
 
, 
 
 
 
,
 
 
 
, 
 
 
 
, 
 
 
 
,
 
  
 
, 
 
 
 
, 
 
 
 
, and 
 
 
 
. However, their nonredundant func-
tions remain mostly unresolved (for review see 1). Among
the PKC family, PKC
 
  
 
is predominantly expressed in T
 
lymphocytes (2–4) and it has been shown that overexpression
 
or inhibition of PKC
 
  
 
in T cell lines can affect activation of
the IL-2 promoter (5–7). In T cell lines, PKC
 
  
 
thereby me-
diates activation of activator protein 1 (AP-1; references
5–8) and nuclear factor (NF)-
 
 
 
B (9–13). The physiological
role of PKC
 
  
 
in TCR/CD28-induced AP-1 and NF-
 
 
 
B
activation was established in the first mouse genetic analysis
of PKC
 
  
 
(14).
PKC
 
  
 
selectively localizes into the center of the ma-
ture i-synapse during antigen stimulation (15). TCR/CD3
stimulation was essential for recruitment and enzymatic ac-
tivation of PKC
 
  
 
(10, 13, 16) and this was found to be
mediated by a nonconventional PI-3K/Vav-1–dependent
pathway (17–19) and not dependent on phospholipase
C-
 
 
 
1 (PLC
 
 
 
1) and diacylglycerol formation (known to
otherwise nonspecifically activate all T cell–expressed con-
ventional and novel isotypes, PKC
 
 
 
, 
 
 
 
, and 
 
 
 
, 
 
 
 
, 
 
 
 
, and 
 
 
 
,
respectively; reference 20).
To further investigate the critical role of PKC
 
 
 
, we inde-
pendently generated PKC
 
 
 
-deficient mice. Analysis of our
PKC
 
 
 
-deficient T cells revealed reduced proliferation and
IL-2 production, entirely consistent with the previous work
(5, 8–14). The observed role of PKC
 
  
 
in TCR/CD28-
induced AP-1 and NF-
 
 
 
B activation was already evident from
the first mouse genetic analysis of PKC
 
  
 
(14). However, un-
expectedly and in contrast to Sun et al. (14), here we report
 
that PKC
 
  
 
is involved in TCR-induced Ca
 
2
 
  
 
responses and
that TCR-mediated NFATp and NFATc transactivation is
primarily impaired in PKC
 
 
 
-deficient mature CD3
 
  
 
T cells.
These findings provide genetic evidence that PKC
 
  
 
may ex-
ert an unexpected proximal role upstream of PLC
 
 
 
1.
 
Materials and Methods
 
Generation of PKC
 
 
 
 
 
/
 
  
 
Mice.
 
A genomic PKC
 
  
 
clone, con-
taining the exons 2–4 encoding the AUG start codon (for the
gene locus organization, see 21), was isolated from a 129/J library
and used to construct the targeting vector (see Fig. 1 A). E14 ES
 
C. Pfeifhofer and K. Kofler contributed equally to this work.
Address correspondence to Gottfried Baier, Institute of Medical Biol-
ogy and Human Genetics, University of Innsbruck, Schoepfstraße 41,
A-6020 Innsbruck, Austria. Phone: 43-512-507-3451; Fax: 43-512-507-
2861; E-mail: Gottfried.Baier@uibk.ac.at
 
*
 
Abbreviations used in this paper:
 
 AP-1, activator protein 1; CCE, capac-
itative Ca
 
2
 
  
 
entry; EMSA, electrophoretic mobility shift assay; IP
 
3
 
, inosi-
tol 1,4,5-trisphosphate; NF, nuclear factor; PDBu, phorbol ester; PKC,
protein kinase C; PLC
 
 
 
1, phospholipase C-
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cells were transfected with linearized targeting vector and after
the selection of colonies with G418, homologous recombina-
tion events were identified by Southern blot analysis and ob-
tained at a frequency of 1:100. The PKC
 
 
 
flox allele we gener-
ated is a extended allele, owing to the presence of a floxed
(flanked by loxP sequences) neo expression cassette inserted in
the unique SpeI site within intron 2 (see Fig. 1 A). A third loxP
site was inserted into the PstI site in intron 4. Positive clones
were used to generate chimaeric founder mice by microinjec-
tion into C57BL/6J blastocysts, generating a conditional PKC
 
 
 
knockout mouse. Germline transmission was confirmed by
Southern blot analysis of tail DNA. PKC
 
 
 
flox/
 
  
 
females were
crossed with C57BL/6J males ubiquitously expressing the Cre
transgene (Cre
 
 
 
/
 
 
 
), resulting in complete gene deletion of the
PKC
 
 
 
flox allele in PKC
 
 
 
flox/
 
  
 
Cre
 
 
 
/
 
  
 
mice. DNA was extracted
from adult tail tissue, digested with BglII, and hybridized with
an endogenous 3
 
 
 
-probe (indicated in Fig. 1 A) distinguishing
wild-type (
 
 
 
/
 
 
 
), heterozygote mutant (
 
 
 
/
 
 
 
), and homozy-
gote mutant (
 
 
 
/
 
 
 
) alleles (see Fig. 1 B). Alternatively, mice car-
rying PKC
 
 
 
 
 
/
 
  
 
were routinely genotyped by PCR (see Fig. 1 C)
using the primers E5.2-S (5
 
 
 
-GCA GAC CCA GAC CAT
TCC CTA G-3
 
 
 
)/E10.5–3 (5
 
 
 
-GGT AGT CTC GGA TGG
TTG AGG G-3
 
 
 
) to detect the mutant allele (2kb product) and
E5.2-S (same as above)/E5.2-CRE (5
 
 
 
-CGC ATT CGT CTA
CAT GAT AAC CGA C-3
 
 
 
) to detect the wild-type allele (1.2-
kb product). Homozygote PKC
 
  
 
mutant (
 
 
 
/
 
 
 
) mice were fur-
ther backcrossed into C57BL/6J background (
 
n
 
    
 
3) before
functional analysis.
 
Apoptosis in Thymocytes and Mature Lymphocytes.
 
Freshly iso-
lated thymocytes from 6–8-wk-old mice were plated at 5 
 
  
 
10
 
6
 
cells ml
 
 
 
1
 
. Cells were stimulated for 24 h with 10 
 
 
 
g ml
 
 
 
1 
 
anti-
CD3 and camptothecin (0.5 and 1 
 
 M), stained with propidium
iodide (0.005% propidium iodide, 0.1% Na citrate, and 0.1% Tri-
ton X-100), and viability was determined by flow cytometry.
Flow Cytometry. Single cell suspensions were prepared and
incubated for 30 min on ice in staining buffer (phosphate-buf-
fered saline containing 2% FCS and 0.2% NaN3) with fluorescein
isothiocyanate and phycoerythrin antibodies. Surface marker ex-
pression of thymocytes, splenocytes, or lymph nodes was ana-
lyzed using a FACScan™ cytometer (Becton Dickinson) and
CellQuest™ software according to standard protocols. Antibodies
against murine CD3 (145-2C11), CD4, and CD8 were obtained
from Caltag Laboratories and CD28(37.51), CD69, CD44, and
CD25 and were obtained from BD Biosciences.
Proliferation Assays. Mature CD3  T cells were purified from
pooled spleen and lymph nodes with mouse T cell enrichment
columns (R&D Systems). T cell populations were typically 95%
CD3   as determined by staining and flow cytometry. Thy-
mocytes were prepared directly from freshly isolated thymi. For
anti-CD3 stimulations, 5   105 T cells in 200  l proliferation
medium (RPMI supplemented with 10% FCS, 2 mM l-glu-
tamine, and 50 units ml 1 penicillin/streptomycin) were added
in duplicates to 96-well plates precoated with 10  g ml 1 anti-
CD3 antibody (clone 2C11). Alternatively, 10 ng ml 1 phorbol
ester (PDBu; Sigma-Aldrich) plus Ca2  ionophore (ionomycin,
50–500 ng ml 1 as indicated; Sigma-Aldrich) were used. Where
indicated, IL-2 (final concentration 40 units ml 1) or soluble 1  g
ml 1 anti-CD28 was also added. Cells were harvested at 64 h after
a 16-h pulse with 1  Ci [3H]thymidine per well and incorpora-
tion of [3H]thymidine was measured with a Matrix 96 direct
  counter system. For the mixed lymphocyte reaction assays,
T cells were purified from littermate mice (B6 background)
and mixed in duplicates at various densities with mitomycin
C–treated splenocytes from BALB/c mice. After 48 h of growth,
the cells were pulsed for 16 h with 1  Ci [3H]thymidine.
IL-2 Production. IL-2 produced from the cultures was mea-
sured via the IL-2–dependent indicator cell line CTLL-2. T cells
were plated in 96-well plates and incubated with the described
stimuli. Plates were then frozen at  20 C. After centrifugation, su-
pernatants were added to CTLL-2 cells (104/well) and cultured for
an additional 48 h and pulsed for 6 h with 1  Ci [3H]thymidine per
well. A standard curve was established by using recombinant IL-2.
Western Blot Analysis. T cells were stimulated with PBS (con-
trol), solid phase hamster anti–CD3 (clone 145-2C11; BD Bio-
sciences), or solid phase hamster anti–CD3 (clone 145-2C11) plus
hamster anti–CD28 (clone 37.51; BD Biosciences) at 37 C for
various time periods. Cells were lysed in ice cold lysis buffer (5
mM NaP2P, 5 mM NaF, 5 mM EDTA, 50 mM NaCl, 50 mM
Tris, pH 7.3, 2% NP-40, 50  g/ml each aprotinin, and leupeptin)
and centrifuged at 15,000 g for 15 min at 4 C. Protein lysates or
immunoprecipitates were subjected to Western blotting using an-
tibodies against PKC ,  ,  , and  /  (Santa Cruz Biotechnology,
Inc.) or PKC  and Fyn (Upstate Biotechnology). Cell fraction-
ation was performed by lysis in equivalent amounts of different
buffers (s fraction: soluble, without detergent; pt fraction: particu-
late, containing 1% NP-40; ns fraction: nonsoluble, containing
2% SDS). To detect the transcription factors, mAb 7A6 for
NFATc (Affinity BioReagents, Inc.), mAbG1-D10 for NFATp
(Santa Cruz Biotechnology, Inc.), and pAb for cfos, cJun, and p50
(Geneka) were used. Tyrosine phosphorylation was monitored in
total cell lysates and PLC 1 immunoprecipitates using an an-
tiphosphotyrosine mAb (4G10; Upstate Biotechnology) and a
pAb reactive to (p)Y783 of PLC 1 (Biosource International).
Gel Mobility Shift Assays. Nuclear extracts were harvested
from 2    107 cells according to standard protocols. Mature
CD3  T cells were purified from pooled spleen and lymph
nodes, washed in PBS, and resuspended in 10 mM Hepes, pH
7.9, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT,
and protease inhibitors. Cells were incubated on ice for 15 min.
NP-40 was added to a final concentration of 0.6%, the cells were
vigorously vortex mixed, and the mixture was centrifuged for 5
min. The nuclear pellets were washed twice and resuspended in
20 mM Hepes, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM
EGTA, 1 mM DTT, and protease inhibitors, and the tube was
rocked for 30 min at 4 C. After centrifugation for 10 min, the
supernatant was collected. 2  g extract proteins were incubated
in binding buffer with end-labeled, double stranded oligonucle-
otide probes (NF- B: 5 -GCC ATG GGG GGA TCC CCG
AAG TCC-3 ; AP-1: 5 -CGC TTG ATG ACT CAG CCG
GAA-3 ; and NFAT: 5 -GCC CAA AGA GGA AAA TTT
GTT TCA TAC AG-3 ). 3   105 cpm of labeled probe was used
in each reaction and band shifts were resolved on 5% polyacryl-
amide gels. All experiments have been performed at least three
times with similar outcomes.
Intracellular Calcium Measurements. For dye loading, 5   106
freshly isolated mature CD3  T cells, from pooled spleen and
lymph nodes, were loaded for 30 min with fura-2 acetoxymethyl-
ester (Molecular Probes). For detection of cytosolic Ca2 , cells
were incubated with 5  g ml 1 biotinylated anti-CD3 (clone 145-
2C11; BD Biosciences) for 15 min at 4 C. Cells were washed with
Hepes buffer (HBS: 20 mM Hepes/NaOH, pH 7.4, 140 mM
NaCl, 5 mM KCl, 1 mM CaCl2, 0.5 mM MgCl2, 5.5 mM glu-
cose) and anti-CD3 molecules were cross-linked at room tempera-
ture using 5  g ml 1 streptavidin (Sigma-Aldrich). For determina-
tion of the cytoplasmic Ca2  concentration ([Ca2 ]i), fluorescence
was measured by a Spex Fluorolog 2 spectrofluorometer (CM-1)T
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1527 Pfeifhofer et al.
equipped with two excitation monochrometers and a chopper sys-
tem as previously described (22). Nanomolar values of cytoplasmic
Ca2  concentration were calculated from the ratios of background
subtracted images (excitation wavelength 350 and 385 nm, emis-
sion wavelength 510 nm) according to the calibration procedure
and equations previously described (23). Experiments have been
performed at least four times with similar outcomes.
Inositol 1,4,5-Trisphosphate (IP3) Measurement. Mature CD3 
T cells were stimulated by cross-linking of CD3 as described
above. The stimulations were terminated by the addition of ice
cold TCA followed by 15 min of incubation on ice. The samples
were centrifuged at 1,400 g at 4 C for 15 min, and the supernatant
was extracted with 10 vol water-saturated diethyl ether neutralized
with 1 M NaHCO3. IP3 was quantitated in duplicate samples using
a competitive [3H]IP3 binding assay (Amersham Biosciences) ac-
cording to the manufacturer’s instructions. Experiments have been
performed at least three times in duplicates with similar outcomes.
Results
Generation of PKC  /  Mice. To study the in vivo
function of PKC  in mice, we generated a null allele (from
the conditional allele, PKC flox) using the Cre/loxP sys-
tem. The PKC  mutation (deletion of exons 3 and 4 en-
coding amino acids 10–87) resulted in a frame shift after
amino acid residue 9 of mouse PKC  (Fig. 1 A). However,
the selectively testis-expressed PKC II mRNA variant (via
alternative splicing from a PKC II-specific exon located
between exons 7 and 8 of the PKC I wild-type gene; ref-
erence 24) has not been disrupted by our targeting strategy.
ES cell lines heterozygous for the mutation at the PKC 
locus were used to generate chimeric mice, which were
backcrossed to C57BL/6J to obtain heterozygous PKC 
mice. The intercross of these mice produced homozygous
PKC -deficient ( / ) mutant mice, which are distinguish-
able by Southern blot and/or PCR genotyping (Fig. 1, B
and C). The null mutation of PKC  in thymocytes as well
as mature T lymphocytes derived from PKC  /  mice was
confirmed by Western blotting using two distinct epitopes
within the PKC  protein. Consistent with our targeting
strategy, no PKC  protein could be detected. This includes
no aberrant T cell expression of PKC II (Fig. 1, D and E).
Figure 1. Targeted disruption of the PKC  lo-
cus. (A) Schematic representation of the murine
wild-type PKC  locus (top) showing NH2-terminal
exons (1–5, open arrows) and the PKC  conditional
knockout allele (flox). Due to targeting vector
design, Cre-mediated recombination deletes the
complete coding sequence of exons 3 and 4, induc-
ing a frame shift mutation between exons 2 and 5,
resulting in an only 9 amino acid residual open
reading frame of the mutated PKC   locus. The
position of the 3  flanking probe as well as PCR
primers E5.2-Cre, E5.2-S, and E10.5-3, which
were used for genotyping, are indicated. (B) Geno-
mic DNA was digested with BglII and hybridized
to the 3  flanking probe. Wild-type and mutant 
bands are indicated. (C) PCR genotyping using
primer pairs E5.2-S/E10.5-3 (to detect a 2 kb mu-
tant   allele-derived product) and E5.2-S/E5.2-
CRE (to detect a 1.2-kb wild-type  allele-derived
product). (D and E) Western blot analysis of 5  
106/lane thymocytes (D) and mature purified
CD3  T cells (E). Antibodies were directed against
PKC  (using distinct epitopes in N or C terminus,
respectively), PKC ,  ,  ,  / , and p59fyn, with the
latter as loading control, as indicated.T
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1528 PKC  Regulates NFAT Activation
As controls, neither thymocyte-expressed PKC isotypes
tested, e.g. PKC ,  ,  , nor  /  showed any deregulated
expression levels in T cells derived from PKC  /  mice.
PKC  /  mice were born at the expected Mendelian fre-
quency, were fertile, and appeared healthy and anatomi-
cally normal as tested up to 9 mo of age. Thymocyte num-
bers and development appeared to be unaffected by the
PKC  mutation. Double-positive thymocytes were able to
differentiate into normal total numbers of CD4  or CD8 
T cells, which expressed normal levels of CD3 (Table I).
Moreover, the relative and total numbers of mature CD4 
and CD8  T cells in the lymph nodes and spleen were
comparable between PKC  /  and wild-type littermates. In
addition, no significant difference in the susceptibility of
thymocytes as well as mature T lymphocytes from adult
PKC  /  mice to ex vivo apoptotic stimuli was observed
(not depicted).
Impaired Antigen Receptor–induced Proliferation and Activa-
tion of PKC -deficient T Lymphocytes. Because of PKC ’s
predominant expression in lymphocytes of the T cell lin-
eage (2–4), we then investigated TCR/CD3 signaling
functions in T cells. Activation of resting T lymphocytes
(resulting in IL-2 cytokine secretion and subsequent prolif-
eration) is known to require stimulation of the TCR–CD3
complex (plus the CD28 auxiliary receptor) or treatment
with pleiotropic PDBu plus Ca2  ionophore. As a result,
purified mature T cells (Fig. 2 A) from wild-type mice
proliferated upon stimulation with plate-bound agonistic
anti-CD3 antibody (with or without anti-CD28 costimu-
lation). However, PKC  /  T cells neither proliferated
well in response to anti-CD3 nor anti-CD3/anti-CD28
stimuli. Similarly, PKC     thymocytes demonstrated re-
duced proliferation rates when compared with wild-type
thymocytes (not depicted). The addition of exogenous IL-2
at 40 units ml 1 almost completely restored the anti-
CD3–induced proliferative response of the mutant T cells,
indicating that the CD25 surface expression (see below) as
well as signaling events downstream of this IL-2 high affin-
ity cytokine receptor remained mostly intact. Treatment
with PDBu in combination with Ca2  ionophore (iono-
mycin) induced comparable proliferation of wild-type as
well as PKC  /  T cells (Fig. 2 B). This finding suggests
that the signaling elements downstream of the antigen re-
ceptor remain mostly intact. In addition, it indicates that
recruitment of other T cell–expressed conventional or
novel PKC isotypes as well as RasGRP (responsive to
PDBu/diacylglycerol) may compensate for the absence of
PKC  to restore the biological response.
The marked decrease in proliferation, observed in
PKC -deficient mature T cells stimulated with anti-CD3
(with or without anti-CD28 costimulation) was accompa-
nied by a significant albeit not complete reduction in the
level of secreted IL-2 (Fig. 3 A). Similarly, PKC -deficient
thymocytes demonstrated significant reduction in the level
of secreted IL-2 (not depicted). In response to either of
these stimuli, neither proliferation (Fig. 2 A) nor IL-2 se-
cretion (Fig. 3 A) of mature T cells from the heterozygous
PKC  /  mice was reduced relative to that of wild-type T
cells indicating haplosufficiency. Again, treatment with
PDBu plus ionomycin induced comparable IL-2 secretion
of wild-type as well as PKC  /  T cells. Thus, loss of
PKC  in T cells results in partially defective IL-2 cytokine
production and cell cycle progression. However, in the ab-
sence of PKC , T cell proliferation and IL-2 secretion de-
fects were restored by treatment with PDBu plus Ca2 
Table I. Flow Cytometric Analyses of PKC     Thymocytes
Cell subset Wild-type PKC    
Thymus
CD4  CD8  91.5   0.28 91.02   0.33
CD4  CD8  5.94   0.29 6.88   0.34
CD4  CD8  1.03   0.13 0.84   0.04
CD4  CD8  1.54   0.13 1.27   0.02
CD3  21.73   0.95 29.37   0.31
Consistently, cellularity of spleens and lymph nodes was comparable in
wild-type and PKC     mice (not depicted).
Percentages   SEM of positive cells per total cells.
Figure 2. Impaired T cell activation in PKC     mice. Proliferative re-
sponses of purified mature CD3  T cells of wild-type (wt), PKC  / , and
PKC  / . After incubation with medium alone and (A) various stimuli
such as anti-CD3 (96-well plates were precoated with a concentration of
10  g ml 1), with or without 1  g ml 1 soluble anti-CD28, 40 units ml 1
human, recombinant IL-2, or (B) 10 ng ml 1 PDBu and ionomycin (at a
range from 50 to 500 ng ml 1, as indicated) for 48 h, cultures were pulsed
for 16 h with 1  Ci [3H]thymidine per well and cells were then harvested
and analyzed using standard procedures. Results shown are the mean  
SD [3H]thymidine incorporation of at least five independent experiments.T
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1529 Pfeifhofer et al.
ionophore (Figs. 2 B and 3 A), stimuli known to bypass an-
tigen receptor ligation. This indicates that the PKC -
dependent and unique upstream pathway specific for TCR
engagement is distinct from pathways used by pleiotropic
PDBu-induced PKC activation.
Using the primary mixed lymphocyte reaction assay, we
evaluated wild-type as well as PKC  /  mature T cell pro-
liferation induced by allogenic MHC expressed on BALB/c
mice–derived splenocytes. Consistent with the results pre-
sented in Fig. 2 A, a significant decrease in proliferation
was observed in PKC -deficient T cells (Fig. 3 B). Co-
treatment with exogenous IL-2 at 40 units ml 1 or treat-
ment with PDBu/ionomycin restored almost normal pro-
liferative responses of the PKC  /  T cells (not depicted).
Consistent with the phenotype of our null allele PKC  / ,
PKC -deficient T cells from the first knockout mouse did
produce less IL-2 and failed to proliferate strongly in re-
sponse to TCR or allogenic MHC stimulation (14).
TCR-induced S phase entry of resting T cells is known
to promote transcriptional up-regulation of IL-2 as well as
IL-2 receptor   chain (CD25) genes, thereby constituting
the autocrine cycle of IL-2 cytokine and its high affinity re-
ceptor. Surprisingly, and in spite of the severe reduction of
TCR-induced IL-2 cytokine production, CD3/CD28 li-
gation–induced expression of CD25 (as well as the activa-
tion markers CD69 and CD44) was not significantly re-
duced in PKC  /  T cells when compared with wild-type
T cells (Fig. 4). This activation-induced CD25 expression
in PKC  /  T cells was consistently observed, even when
using a range of anti-CD3 concentrations (0.25–1  g ml 1,
with or without 1  g ml 1 anti-CD28) as well as stimula-
tion time frames from 16 to 24 h (not depicted). Consistent
with this almost normal expression of the high affinity IL-
2R, the addition of exogenous IL-2 mostly rescued the
proliferative defect in PKC  /  T cells (Fig. 2 A). A signal
transducing pathway involving activation and translocation
of other PKC isotype(s) and/or RasGRP family members
may therefore regulate expression of CD25 (as well as
CD69 and CD44). Alternatively, expression of CD25 in
PKC  /  T cells might be rescued by the residual but still
significant IL-2 production of these cells, known to activate
CD25 expression independent of TCR signaling. CD25
transcription is now known to be controlled by binding of
HMG-I(Y), Stat5a, and Stat5b in vivo to upstream positive
regulatory regions III and IV, which function as IL-2 re-
sponse elements (25). Of note, similar reduction of IL-2
cytokine production but almost normal CD25 expression
has been described in itk-deficient T cells (26).
PKC  Is Essential for Antigen Receptor–induced NFAT Ac-
tivation. To further elucidate the molecular basis of the
impairment in antigen receptor signaling in the absence of
PKC , we analyzed the critical NF- B, AP-1, and NFAT
pathways, known to be PKC dependent (27) and critical in
TCR/CD28-induced IL-2 cytokine expression (28–31).
Electrophoretic mobility shift assays (EMSAs) demonstrated
that substantial NF- B, AP-1, and NFAT DNA binding
activity was induced in wild-type CD3  mature T cells af-
ter anti-CD3/anti-CD28 stimulation. In contrast, a signifi-
cant albeit partial decrease in NF- B and AP-1 activation
in PKC  /  cells has been reproducibly observed (Fig. 5, A
and B). Most surprisingly, CD3 cross-linking completely
failed to fully activate the calcineurin-dependent transcrip-
tion factors NFATp ( NFAT1) and NFATc ( NFAT2)
in these cells (Fig. 5 C). Establishing a time course of CD3/
CD28-induced NFAT activation, a significant decrease in
NFAT DNA binding in PKC     cells has been reproduc-
ibly observed at 4, 8, and particularly at 16 h (Fig. 5 D),
consistent with the observed lack of full T cell activation in
PKC     T cells.
To exclude protein expression defects of the transcrip-
tion factors studied, total cell extracts of resting and stimu-
lated T cells from both wild-type and PKC  /  T cells
were investigated. As a result, the activation-dependent
up-regulation of fos, jun (Fig. 6 A), and the induction of
the three prominent isoforms of NFATc (32) as well as
NFATp was not altered in the PKC  /  T cells (Fig. 6, B
and C), excluding signaling defects caused by simply differ-
ent expression levels. However, the expression of p50NF- B
was significantly reduced in PKC -deficient T cells (Fig. 6
Figure 3. Impaired IL-2 secretion in PKC     mice. IL-2 cytokine se-
cretion responses of (A) purified mature CD3  T cells of wild-type / ,
PKC  / , and PKC  / . IL-2 concentration in the supernatants of cul-
ture treated with various stimuli: medium, anti-CD3 (precoated with a
concentration of 10  g ml 1), 1  g ml 1 soluble anti-CD28, 10 ng ml 1
PDBu, and 1  g ml 1 ionomycin, as indicated. IL-2 produced from the
cultures was measured by quantifying the proliferation of the IL-2–
dependent indicator cell line CTLL-2. Cells were then harvested and an-
alyzed using standard procedures. (B) For the mixed lymphocyte reaction
assays, purified mature CD3  T cells of wild-type /  and PKC  /  litter-
mates were mixed in duplicates at various densities with mitomycin
C–treated splenocytes from BALB/c mice, as indicated. After 48 h of
growth, the cells were pulsed for 16 h with 1  Ci [3H]thymidine. Results
shown are the mean   SD [3H]thymidine incorporation of at least four
independent experiments.T
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1530 PKC  Regulates NFAT Activation
A), potentially indicating such an indirect effect in the NF-
 B signaling pathway of PKC  /  T cells.
PKC  Is Required for the Antigen Receptor–induced Calcium
Signal. Given the greatly reduced TCR-induced NFAT
activation in our PKC  / -derived T lymphocytes, we in-
vestigated if PKC  might regulate TCR-induced Ca2  mo-
bilization, and subsequently downstream calcineurin and
NFAT transactivation. We loaded mature CD3  T cells
taken from PKC  /  and wild-type T cells with the intra-
cellular Ca2  indicator dye fura-2 and imaged increase of
intracellular Ca2  over time in response to the cross-linking
of biotinylated anti-CD3 antibodies by streptavidin. Unex-
pectedly, we were able to distinguish different patterns of
intracellular Ca2  elevation and PKC  /  T cells failed to
mobilize similar intracellular Ca2  levels compared with
wild-type littermates (Fig. 7 A). Wild-type T cells repro-
ducibly demonstrate a steeper onset of Ca2  signal (Fig. 7 B)
with total cytosolic Ca2  levels remaining roughly 60–80
nM higher than in the PKC  /  T cells (Fig. 7 C). Ca2  re-
sponses in cells stimulated by Ca2  ionophore remained in-
tact in PKC -deficient T cells (Fig. 7 A). This might be ex-
plained by ionomycin’s ability to deplete internal stores of
Figure 4. Flow cytometric analysis of expression of
CD25, CD44, and CD69 on PKC     T cells. Single
cell suspensions of purified mature CD3  T cells stimu-
lated or not for 16 h with anti-CD3 and anti-CD28,
were stained with anti-CD25, anti-CD44, and anti-
CD69. Percentages of positive cells are indicated. Ex-
periments were repeated at least three times in dupli-
cates with similar results.T
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Ca2  as well as its direct effect on the plasma membrane.
Given the identical CD3 surface expression in both T cell
populations (Table I and not depicted), the stronger, i.e.,
more rapid response in wild-type T cells might indicate a
different sensitivity state, with only this robust wild-type
Ca2  response correlating with sustained NFAT transactiva-
tion (refer to Fig. 5 D).
Ca2  mobilization in T cells is initiated by membrane
association and enzymatic activation of PLC 1, which
catalyzes the breakdown of phosphatidylinositol-4, 5-bis-
phosphate into IP3, a stimulant for Ca2  store depletion.
Wild-type cells showed maximal IP3 levels within 30 s after
stimulation, consistent with rapid activation of PLC 1 (Fig.
7 D). In contrast, the TCR-driven production of IP3 was
significantly albeit partially diminished in PKC  /  T cells,
indicating that this partial defect might be the cause of al-
tered Ca2  mobilization in these cells. In addition, anti-
CD3 stimulation revealed no apparent differences in the
phosphorylation of Erk1/Erk2 (Fig. 7 E) in PKC  /  T
cells. Of note, CD3-induced tyrosine phosphorylation at
Y783 of PLC 1 was not significantly changed in PKC  /  T
cells (not depicted), consistent with the moderate reduction
of PLC 1 activation in these cells.
These data suggest that PKC  physiologically operates
upstream of the membrane-associated Ca2  signaling scaf-
fold in T cells, which mainly comprises the transmembrane
adaptor protein LAT, the cytosolic adaptor proteins Gads
and SLP-76, and the effector molecules PLC 1 and itk (a
PTK of the Tec family). Along this line of argumentation,
in T cell lines we have shown that PKC  (but not PKC )
membrane recruitment is, at least in part, independent of
PLC 1 (19). Second, and again consistent with this hy-
pothesis, a very rapid and complete cytosol to membrane
translocation of endogenous PKC , and to a lesser degree
of endogenous PKC , could be observed already after 1
min of CD3 cross-linking (Fig. 7 F).
Discussion
Proliferation of T cells after cross-linking of the TCR is
a consequence of up-regulated transcription of the IL-2 cy-
tokine gene. IL-2 expression requires NFAT activation,
synthesis, phosphorylation, and activation of members of
the Fos and Jun families as well as activity of NF- B. All
critical transcription factors act synergistically on composite
DNA elements within the IL-2 promoter (27–29, 33, 34).
Figure 5. EMSA analysis of NF- B, AP-1, and NFAT
in PKC     T cells. Nuclear extracts were prepared from
purified mature CD3   wild-type and PKC      T cells
stimulated for 16 h with medium alone or plate-bound
anti-CD3 plus soluble anti-CD28 as indicated. Gel mobil-
ity shift assays were performed using radiolabeled probes
containing either (A) NF- B, (B) AP-1, and (C and D)
NFAT-binding site sequences. (D) To study the time
course of NFAT activation, CD3  T cells were stimulated
for 4, 8, and 16 h with anti-CD3 plus anti-CD28 or me-
dium alone as indicated. The specificity of p50 NF- B as
well as NFATc and NFATp was confirmed by supershift-
ing the electrophoretic mobility shift with antibodies as in-
dicated by the arrow. Experiments were repeated at least
three times with similar results.T
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As shown in this study, PKC  /  T cells failed to proliferate
in response to TCR stimulation (Fig. 2 A) or allogenic
MHC (Fig. 3 B). The reduced proliferative response was
due to markedly decreased levels of IL-2 (Fig. 3 A). Con-
sistently, in PKC  /  T cells, TCR/CD28-induced NF- B
and AP-1 activation was significantly reduced and NFAT
activation was abrogated below the detection level (Figs. 5
and 6). The distal NFAT site within the IL-2 promoter is
Figure 6. Protein expression analysis of p50,
cfos, cjun, and NFAT in PKC     T cells. To
control for the normal levels of protein expres-
sion of the transcription factors studied in
EMSA, whole cell extracts of resting and 16 h–
activated T cells were immunostained with the
specific antibodies as indicated. Immunostaining
of p59fyn served as equal protein loading control.
Figure 7. PKC  is required for normal TCR-
driven calcium mobilization but not for ERK acti-
vation. (A) Purified mature CD3  T cells (purified
from pooled spleen and lymph nodes) were loaded
with Fura-2 and monitored for changes in intracel-
lular-free calcium [Ca2 ]i. CD3 cross-linking was
induced by streptavidin and direct Ca2  influx with
ionomycin. (B and C) Ca2  signaling patterns from
four representative experiments performed in du-
plicates are statistically analyzed. Slope (B, nM/s)
and plateau (C, nM) of intracellular Ca2  varied sig-
nificantly in PKC -deficient cells (P   0.01). (D)
Graphs showing the mean levels of IP3 stimulated
by cross-linking of CD3 as above for 0, 30, and 60 s.
Detected IP3 levels ranged from 0.2 pmol/107
cells  (unstimulated cells) to 0.8 pmol/107  cells
(wild-type stimulated cells). Results shown are the
mean   SD of at least three independent experi-
ments. (E) Total cell lysates were immunostained
sequentially with anti–phospho-MAPK that detects
dually phosphorylated (active) ERK1, ERK2, and
anti-ERK1/2 that recognizes pan-ERK. (F) Kinet-
ics of subcellular translocation of endogenous PKC
isotypes in Jurkat T cells as indicated. The cell frac-
tions are defined as the soluble (s, cytosol) fraction,
the particulate (pt, predominantly plasma mem-
brane) fraction, and the NP-40 nonsoluble fraction
(ns, predominantly cytoskeleton, detergents insolu-
ble membrane domains). As internal control for cell
fractionation, immunostaining of p59fyn predomi-
nantly recognized the particulate fraction.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
1533 Pfeifhofer et al.
known to cooperatively bind NFAT and AP-1 (35), and
therefore the relative contribution of PKC  to NFAT ver-
sus AP-1 activation is not yet resolved. Nevertheless,
TCR-induced sustained Ca2  mobilization was altered and
significantly reduced in PKC  /  T cells (Fig. 7 A), indicat-
ing that the Ca2 /NFAT pathway might play a critical role
in the IL-2 promoter activation by PKC . Of note, the re-
duced Ca2  mobilization in PKC  /  T cells might poten-
tially explain, at least in part, the observed partial reduction
of NF- B and AP-1 transactivation, signaling pathways
both known to be sensitive to the amplitude and duration
of the Ca2  signal (6, 36).
Sun et al. (14) partially inactivated the PKC  gene by
homologous recombination by replacing the exon 11 (with
a neomycin resistance gene expression cassette). These two
distinct PKC  knockout mouse lines (14 and this study) are
identical in regard to their genetic background (129-
C57BL/6J). Consistent with the phenotype of our null al-
lele PKC  / , T cell development was shown to be unaf-
fected in the absence of PKC  and PKC  /  T cells did
produce less IL-2 and failed to proliferate strongly in re-
sponse to TCR stimulation (14). Surprisingly, however,
major discrepancies have been observed (Table II). Mature
T lymphocytes from PKC  heterozygous mice show nor-
mal TCR-induced IL-2 responses (haplosufficiency, Fig. 3
A) but impaired IL-2 responses (haploinsufficiency) in the
studies of Sun et al. (14). In addition, PKC  /  T cells did
produce normal PDBu and ionomycin induced prolifera-
tion (Fig. 2 B) and IL-2 secretion (Fig. 3 A) as well as nor-
mal CD3/CD28-induced up-regulation of CD25 (as well
as CD69) surface expression (Fig. 4). These signal path-
ways, however, were shown to be impaired by Sun et al.
(14). Next and most importantly, the PKC  / -derived
mature T cells in our current study are primarily defective
in TCR-mediated NFAT signaling (Fig. 5), but Sun et al.
(14) observed completely normal TCR-induced NFAT ac-
tivation in their PKC  T cells. Thus, studies of these two
different PKC  knockouts reveal certain fundamental dif-
ferences. Differences might be explained by unintended
defects from a particular targeting strategy, which may in-
clude dominant-negative effects of expressed anomalous
protein or alterations in nearby genes. Such differences
warrant further investigation.
Activation of T lymphocytes through the TCR includes
IP3-mediated elevation of cytosolic [Ca2 ]i  initiated by
Ca2  release from internal stores and subsequent capacita-
tive Ca2  entry (CCE) through stores-operated Ca2  chan-
nels. CCE is an absolute requirement for normal T cell ac-
tivation, i.e., the elevation of [Ca2 ]i must be sustained for
commitment of the lymphocyte to maintain NFAT tran-
scription factors in the nucleus (37) to induce transcription
of the cytokine IL-2 (31). Consistent with our observed
NFAT defect, TCR-induced sustained Ca2  mobilization
was altered and significantly albeit partially reduced in
Table II. Comparison of Two Independent PKC  Knockout Strains
Sun et al. (reference 14) This study
Targeting strategy: Exon 11 replaced by PKG-neo Cre/loxP null allele (deletion of exons 3 and 4)
Residual open reading frame 365 aa 9 aa
Thymocytes:
Development normal normal
Peripheral T cells:
Proliferative responses
to CD3/CD28 impaired impaired
to PMA/ionomycin impaired normal
to allogenic MHC partially impaired partially impaired
IL-2 production
to CD3/CD28 impaired impaired
to PMA/ionomycin impaired normal
Heterozygous phenotype: impaired normal
EMSA/stimulated with CD3/CD28
NF- B impaired partially impaired
AP-1 impaired partially impaired
NFAT normal impaired
Surface expression/stimulated with CD3/CD28
CD69 impaired normal
CD25 impaired normalT
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PKC  /  T cells (Fig. 7 A). This may very well indicate
subcellular signaling defects that can limit the intensity and
duration of highly localized Ca2  spikes. The Ca2  mobili-
zation defect in the PKC -deficient T cells might be due
to any defect in membrane association and enzymatic acti-
vation of PLC 1, which catalyzes the breakdown of phos-
phatidylinositol-4, 5-bisphosphate into IP3, a stimulant for
Ca2  mobilization (for review see 38). Indeed, upon CD3
cross-linking, the overall IP3 production in the PKC  /  T
cell was found to be partially reduced (Fig. 7 D), suggesting
that PLC 1 is less efficiently stimulated in PKC -deficient
T cells. Nevertheless, additional downstream defects of re-
lease of Ca2  stores, disruption of the signal between Ca2 
stores release and Ca2  entry, and direct block of the Ca2 
entry channels that produce CCE in PKC -deficient T
cells cannot be excluded at this point.
Current models suggest that immune responses in T
lymphocytes are exquisitely controlled, requiring multiple
finely tuned levels of activation signals. Even a small distur-
bance of the full Ca2  signal may therefore correlate with
an inability of the stimulus to induce stimulation of cal-
cineurin, which leads to dephosphorylation and nuclear lo-
calization of NFAT (31, 37). Similarly, it has been shown
that a sustained elevation of the intracellular Ca2  concen-
tration is necessary for the activation of the IL-2 promoter
(39). If [Ca2 ]i declines too early after TCR stimulation, a
reverse translocation of NFAT out of the nucleus will oc-
cur (37, 40), thus aborting the immune response. From the
data of Karttunen and Shastri (41) and Valitutti et al. (42), it
also appears that a full and sustained Ca2  stimulus must be
maintained to induce an irreversible commitment to T cell
activation, particularly at lower antigenic peptide con-
centrations. Consistently, immunomodulatory drugs (cy-
closporin A, FK506) are used that target calcineurin and in-
hibit translocation of NFAT. Clinical studies demonstrate
that the dose of cyclosporin A necessary to prevent trans-
plant rejection inhibits only  50% of calcineurin activity in
lymphocytes but is sufficient to abrogate nuclear localiza-
tion of NFATc family members (for review see 33). Along
this line of argumentation, PKC -deficient T cells generate
still detectable, albeit significantly reduced, Ca2  responses.
Given the importance of the sustained phase of the Ca2 
signal, such a small reduction of intracellular Ca2  ion con-
centration might correlate with an inability of the stimulus
to induce IL-2 gene expression and T cell proliferation.
Thus, PKC , unlike the more proximally acting Lck and
ZAP70, may not serve as primary trigger of the immune
response but instead may further refine lymphocyte signal-
ing by acting as a critical signal strength regulator of PLC 1
activation, i.e., as a rate-limiting step in triggering a full T
cell Ca2  signal during antigenic stimulation. Similarly,
such a partial suppression of PLC 1 has been described,
i.e., in the itk-deficient T cells (26).
Taken together, this suggests that PKC  is part of a sig-
naling pathway that is necessary for full T cell activation
and the observed reduction in the IP3 production and sub-
sequent Ca2  response might be responsible for the ob-
served primary defect of NFAT transactivation in PKC  / 
T cells. Thus, PKC  appears critical for efficient signaling
downstream of the TCR and the primary effect of PKC 
loss of function may lie upstream of TCR-induced Ca2 
mobilization. How the loss of PKC  results in defective
Ca2  responses needs to be investigated.
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